Jieti Z. Wang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
The effect of preoperative inflammatory indicators on the prognosis of patients with T1a renal cell carcinoma undergoing surgery and the construction of a predictive model
Journal: Zhonghua yi xue za zhi
Published: March 19, 2026
Lethal clinical outcome and immune desert contexture in refractory gastric cancer harboring CCNE1 amplification and overexpression.
Journal: British journal of cancer
Published: December 20, 2025
CD8+ T Cell Infiltration Elicits Molecular Subtype-Biased Clinical Outcomes in Gastric Cancer Patients.
Journal: Cancer science
Published: September 13, 2025
Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer.
Journal: British journal of cancer
Published: November 30, 2024
Optimization of endoscopic treatment strategies for R0 resection of rectal neuroendocrine tumors smaller than 10 mm.
Journal: Clinics and research in hepatology and gastroenterology
Published: July 19, 2024
Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01).
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 11, 2024
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer.
Journal: British journal of cancer
Published: November 28, 2023
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2023
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.
Journal: Cancer science
Published: October 11, 2023
C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.
Journal: British journal of cancer
Published: November 21, 2022
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer.
Journal: International journal of cancer
Published: November 03, 2022
Last Updated: 09/26/2026